SØG - mellem flere end 8 millioner bøger:

Søg på: Titel, forfatter, forlag - gerne i kombination.
Eller blot på isbn, hvis du kender dette.

Viser: Cancer Genomics for the Clinician

Cancer Genomics for the Clinician, 1. udgave
Søgbar e-bog

Cancer Genomics for the Clinician Vital Source e-bog

Ramaswamy Govindan og MD
(2019)
Springer Publishing LLC
836,00 kr.
Leveres umiddelbart efter køb
Cancer Genomics for the Clinician

Cancer Genomics for the Clinician

Ramaswamy Govindan og Siddhartha Devarakonda
(2019)
Springer Publishing Company, Incorporated
99.999,00 kr.
ikke på lager, Bestil nu og få den leveret
om ca. 10 hverdage

Detaljer om varen

  • 1. Udgave
  • Vital Source searchable e-book (Reflowable pages)
  • Udgiver: Springer Publishing LLC (Januar 2019)
  • Forfattere: Ramaswamy Govindan og MD
  • ISBN: 9780826168689

Cancer Genomics for the Clinician is a practical guide to cancer genomics and its application to cancer diagnosis and care. The book begins with a brief overview of the various types of genetic alterations that are encountered in cancer, followed by accessible and applicable information on next generation sequencing technology and bioinformatics; tumor heterogeneity; whole genome, exome, and transcriptome sequencing; epigenomics; and data analysis and interpretation. Each chapter provides essential explanations of concepts, terminology, and methods. Also included are tips for interpreting and analyzing molecular data, as well as a discussion of molecular predictors for targeted therapies covering hematologic malignancies and solid tumors. The final chapter explains the use of FDA-approved genomic-based targeted therapies for breast cancer, lung cancer, sarcomas, gastrointestinal cancers, urologic cancers, head and neck cancer, thyroid cancer, and many more.

Assembled in an accessible format specifically designed for the non-expert, this book provides the clinical oncologist, early career practitioner, and trainee with an essential understanding of the molecular and genetic basis of cancer and the clinical aspects that have led to advancements in diagnosis and treatment. With this resource, physicians and trainees will increase their breadth of knowledge and be better equipped to educate patients and families who want to know more about their genetic predispositions to cancer and the targeted therapies that could be considered and prescribed.

Key Features:

  • Describes how cancer genomics and next generation sequencing informs cancer screening, risk factors, therapeutic options, and clinical management across cancer types
  • Explains what mutations are, what tests are needed, and how to interpret the results
  • Provides information on FDA-approved targeted therapies that are being used in the clinic
  • Covers different sequencing platforms and technologies and how they perform in research settings
  • Includes access to the fully searchable eBook
Licens varighed:
Bookshelf online: 5 år fra købsdato.
Bookshelf appen: ubegrænset dage fra købsdato.

Udgiveren oplyser at følgende begrænsninger er gældende for dette produkt:
Print: 10 sider kan printes ad gangen
Copy: højest 2 sider i alt kan kopieres (copy/paste)

Detaljer om varen

  • Hardback: 300 sider
  • Udgiver: Springer Publishing Company, Incorporated (Januar 2019)
  • Forfattere: Ramaswamy Govindan og Siddhartha Devarakonda
  • ISBN: 9780826168672

Cancer Genomics for the Clinician is a practical guide to cancer genomics and its application to cancer diagnosis and care. The book begins with a brief overview of the various types of genetic alterations that are encountered in cancer, followed by accessible and applicable information on next generation sequencing technology and bioinformatics; tumor heterogeneity; whole genome, exome, and transcriptome sequencing; epigenomics; and data analysis and interpretation. Each chapter provides essential explanations of concepts, terminology, and methods. Also included are tips for interpreting and analyzing molecular data, as well as a discussion of molecular predictors for targeted therapies covering hematologic malignancies and solid tumors. The final chapter explains the use of FDA-approved genomic-based targeted therapies for breast cancer, lung cancer, sarcomas, gastrointestinal cancers, urologic cancers, head and neck cancer, thyroid cancer, and many more.

Assembled in an accessible format specifically designed for the non-expert, this book provides the clinical oncologist, early career practitioner, and trainee with an essential understanding of the molecular and genetic basis of cancer and the clinical aspects that have led to advancements in diagnosis and treatment. With this resource, physicians and trainees will increase their breadth of knowledge and be better equipped to educate patients and families who want to know more about their genetic predispositions to cancer and the targeted therapies that could be considered and prescribed.

Key Features:

  • Describes how cancer genomics and next generation sequencing informs cancer screening, risk factors, therapeutic options, and clinical management across cancer types
  • Explains what mutations are, what tests are needed, and how to interpret the results
  • Provides information on FDA-approved targeted therapies that are being used in the clinic
  • Covers different sequencing platforms and technologies and how they perform in research settings
  • Includes access to the fully searchable eBook

Chapter One: Introduction to Cancer Genomics Deepali Jain, Brett Herzog, and Leonard B. Maggi, Jr.
Chapter Two: Tumor Mutational Profiling by Next Generation Sequencing Samantha N. McNulty, Latisha Love-Gregory, and Jonathan W. Heusel
Chapter Three: Bioinformatics: What a Clinician Should Know Irena Lanc and Arpad Danos
Chapter Four: Tumor Heterogeneity Alex H. Wagner, Kilannin Krysiak, Katie M. Campbell, and Erica K. Barnell
Chapter Five: Epigenetics Alterations in Cancer Erica C. Pehrsson, Hyo Sik Jang, and Ting Wang
Chapter Six: Cell-Free DNA in Cancer Diagnosis and Follow-Up Bruna Pellini Ferreira and Daniel Morgensztern
Chapter Seven: Optimizing Targeted Therapies Using Next Generation Sequencing Brett Herzog and Saiama N. Waqar

About Springer

Science, technology and medicine play an important role in our daily lives. With Springer at the top, these subjects are quite at home in our publishing houses.

 

Some of the most renowned scientists in the world are our authors. Alongside Springer, with offices in many of the world’s centers of knowledge, the Science / Technology / Medicine (STM) publishers Apress, BioMed Central, Humana, Key Curriculum Press, Spektrum Akademischer Verlag and others enjoy excellent professional reputations.

 

All in all, some 2,000 academic journals and around 6,500 new books are published each year – in Berlin, Heidelberg, Dordrecht, Vienna, Paris, London, Milan, Moscow, New York, Beijing, Tokyo and New Delhi. 90 percent of our publications appear on the market in English.